CD8A and neoplasm: The immune-mediated eradication of established tumors depends on several factors, including the presence of tumor antigen-primed CD8+ effector T cells, the ability of such T cells to traffic to sites of tumor growth, the persistence of cells in sufficient concentrations at the tumor site, and the capacity of the T cells to maintain cytotoxic effector functions in the face of local immunosuppressive mechanisms.